21 related articles for article (PubMed ID: 3621189)
1. Pathogenic roles of alterations in vitamin D and vitamin D receptor in gastric tumorigenesis.
Du C; Yang S; Zhao X; Dong H
Oncotarget; 2017 Apr; 8(17):29474-29486. PubMed ID: 28206978
[TBL] [Abstract][Full Text] [Related]
2. Update of preclinical and human studies of calcium and colon cancer prevention.
Lipkin M
World J Gastroenterol; 1999 Dec; 5(6):461-464. PubMed ID: 11819492
[No Abstract] [Full Text] [Related]
3. Regulation of metallothionein gene expression by 1 alpha,25-dihydroxyvitamin D3 in cultured cells and in mice.
Karasawa M; Hosoi J; Hashiba H; Nose K; Tohyama C; Abe E; Suda T; Kuroki T
Proc Natl Acad Sci U S A; 1987 Dec; 84(24):8810-3. PubMed ID: 3480513
[TBL] [Abstract][Full Text] [Related]
4. Inhibition by 1 alpha, 25-dihydroxyvitamin D3 of induction of epidermal ornithine decarboxylase caused by 12-O-tetradecanoylphorbol-13-acetate and teleocidin B.
Chida K; Hashiba H; Suda T; Kuroki T
Cancer Res; 1984 Apr; 44(4):1387-91. PubMed ID: 6423272
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of tumor promotion in mouse skin by 1 alpha,25-dihydroxyvitamin D3.
Chida K; Hashiba H; Fukushima M; Suda T; Kuroki T
Cancer Res; 1985 Nov; 45(11 Pt 1):5426-30. PubMed ID: 3840412
[TBL] [Abstract][Full Text] [Related]
6. [Regulation of tumor promotion by 1 alpha, 25-dihydroxyvitamin D3, an active form of vitamin D3].
Kuroki T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):766-72. PubMed ID: 3754414
[TBL] [Abstract][Full Text] [Related]
7. Enhancement by 1 alpha,25-dihydroxyvitamin D3 of chemically induced transformation of BALB 3T3 cells without induction of ornithine decarboxylase or activation of protein kinase C1.
Sasaki K; Chida K; Hashiba H; Kamata N; Abe E; Suda T; Kuroki T
Cancer Res; 1986 Feb; 46(2):604-10. PubMed ID: 3000580
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of tumor promoter 12-O-tetradecanoylphorbol-13-acetate-induced synthesis of epidermal ornithine decarboxylase messenger RNA and diacylglycerol-promoted mouse skin tumor formation by retinoic acid.
Verma AK
Cancer Res; 1988 Apr; 48(8):2168-73. PubMed ID: 3349487
[TBL] [Abstract][Full Text] [Related]
9. Similarity and dissimilarity between phorbol ester tumor promoters and 1 alpha,25-dihydroxyvitamin D3, an active form of vitamin D3.
Kuroki T; Suda T
Princess Takamatsu Symp; 1983; 14():89-99. PubMed ID: 6394594
[TBL] [Abstract][Full Text] [Related]
10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
11. Systemic inhibition of tumor promoter-induced ornithine decarboxylase in 1 alpha-hydroxyvitamin D3-treated animals.
Hashiba H; Fukushima M; Chida K; Kuroki T
Cancer Res; 1987 Oct; 47(19):5031-5. PubMed ID: 3621189
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
